Roivant Sciences Stock Market Value
| ROIV Stock | USD 27.52 0.04 0.15% |
| Symbol | Roivant |
What growth prospects exist in Biotechnology sector? Can Roivant capture new markets? Factors like these will boost the valuation of Roivant Sciences. Anticipated expansion of Roivant directly elevates investor willingness to pay premium valuations. Valuation analysis balances hard financial data with qualitative growth assessments. While each Roivant Sciences valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth (0.96) | Earnings Share (1.17) | Revenue Per Share | Quarterly Revenue Growth (0.78) | Return On Assets |
Roivant Sciences's market price often diverges from its book value, the accounting figure shown on Roivant's balance sheet. Smart investors calculate Roivant Sciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Since Roivant Sciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Roivant Sciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Roivant Sciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Roivant Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Roivant Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Roivant Sciences.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Roivant Sciences on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Roivant Sciences or generate 0.0% return on investment in Roivant Sciences over 90 days. Roivant Sciences is related to or competes with Summit Therapeutics, BridgeBio Pharma, Revolution Medicines, Ascendis Pharma, Ionis Pharmaceuticals, EXACT Sciences, and Avidity Biosciences. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines More
Roivant Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Roivant Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Roivant Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.65 | |||
| Information Ratio | 0.1259 | |||
| Maximum Drawdown | 24.15 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 5.43 |
Roivant Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Roivant Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Roivant Sciences' standard deviation. In reality, there are many statistical measures that can use Roivant Sciences historical prices to predict the future Roivant Sciences' volatility.| Risk Adjusted Performance | 0.1184 | |||
| Jensen Alpha | 0.3943 | |||
| Total Risk Alpha | 0.2459 | |||
| Sortino Ratio | 0.2621 | |||
| Treynor Ratio | 0.2835 |
Roivant Sciences February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1184 | |||
| Market Risk Adjusted Performance | 0.2935 | |||
| Mean Deviation | 1.97 | |||
| Semi Deviation | 1.28 | |||
| Downside Deviation | 1.65 | |||
| Coefficient Of Variation | 692.79 | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.81 | |||
| Information Ratio | 0.1259 | |||
| Jensen Alpha | 0.3943 | |||
| Total Risk Alpha | 0.2459 | |||
| Sortino Ratio | 0.2621 | |||
| Treynor Ratio | 0.2835 | |||
| Maximum Drawdown | 24.15 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 5.43 | |||
| Downside Variance | 2.72 | |||
| Semi Variance | 1.64 | |||
| Expected Short fall | (2.59) | |||
| Skewness | 4.09 | |||
| Kurtosis | 24.01 |
Roivant Sciences Backtested Returns
Roivant Sciences appears to be not too volatile, given 3 months investment horizon. Roivant Sciences maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16 % return per unit of risk over the last 3 months. By analyzing Roivant Sciences' technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please evaluate Roivant Sciences' Risk Adjusted Performance of 0.1184, semi deviation of 1.28, and Coefficient Of Variation of 692.79 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Roivant Sciences holds a performance score of 12. The company holds a Beta of 1.71, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Roivant Sciences will likely underperform. Please check Roivant Sciences' maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Roivant Sciences' historical price patterns will revert.
Auto-correlation | 0.06 |
Virtually no predictability
Roivant Sciences has virtually no predictability. Overlapping area represents the amount of predictability between Roivant Sciences time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Roivant Sciences price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Roivant Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 3.77 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.